Results 101 to 110 of about 2,727 (172)

Global landscape of clinical trials for endometriosis: dynamic trends and future directions. [PDF]

Int J Surg
He S, Li H, Wan L, Qin X.
europepmc   +1 more source

Physicians' Perceptions of Intravenous Estrogen for the Management of Acute Abnormal Uterine Bleeding. [PDF]

Cureus
Tjaden Peiffer A, Kistner M, Otto A, Schultz E, Wesolowski M, White P, Yang LC.   +6 more
europepmc   +1 more source

Costs, Demographics, and Causative Agents in Patients Hospitalized for Drug Induced Liver Injury: Trends in a Large Academic Healthcare System. [PDF]

Clin Exp Gastroenterol
Kozar M, Gonzalez Y, Halegoua-DeMarzio D.   +2 more
europepmc   +1 more source

Toward gender equity in contraception: male contraceptive passes safety trial. [PDF]

EBioMedicine
eBioMedicine.
europepmc   +1 more source

Renal atrophy, bowel obstruction, and sciatic nerve impingement secondary to deep endometriosis. [PDF]

CMAJ
Singh SS, Duigenan S, Tanara L, Flaxman TE.   +3 more
europepmc   +1 more source

Hormonal contraceptive effects on the brain: considering the dual impact of endogenous and exogenous hormone flux. [PDF]

Neuropsychopharmacology
Ross A, Eisenlohr-Moul TA.
europepmc   +1 more source

Efficacy and safety of drug combinations for chronic pelvic pain: a systematic review. [PDF]

Pain Rep
Mohiuddin M, Park R, Wesselmann U, Pukall C, Jarvi K, Nickel JC, Doiron RC, Halliday S, Gilron I.   +8 more
europepmc   +1 more source

Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Endometriosis: Advances in Research. [PDF]

J Clin Med Res
Wang JY, Zhang Y, Ding J.
europepmc   +1 more source

The prevalence and burden of heavy menstrual bleeding, and market access barriers of medical interventions with a focus on low- and middle-income countries: a scoping review. [PDF]

BMC Womens Health
Ammerdorffer A, Ferrillo O, Mills K, Guneratne T, Makama M, Romero L, McDougall ARA, Sothornwit J, Lumbiganon P, Bahamondes MV, Scott J, Chinery L, Bahamondes L, Vogel JP, Gülmezoglu AM.   +14 more
europepmc   +1 more source

Melasma secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS). [PDF]

BMC Pharmacol Toxicol
Qu Y, Wang S, Xie H, Meng X, Cui B, Xiao Z.   +5 more
europepmc   +1 more source